Lead-based paint detection using perovskite fluorescence and X-ray fluorescence.

BACKGROUND: Ingestion of flakes of Pb-based paint by infants remains a global health hazard with life-long consequences. Pb-based paint was banned for residential use in the US and Western Europe decades ago but is still sold in many countries. This study evaluates the performance of a new kit for detecting exposed Pb-based paint relying on the formation of Pb-halide perovskite that fluoresces bright green under a UV flashlight after spraying a non-toxic reagent. RESULTS: Tests with the Lumetallix kit were conducted in parallel with X-fluorescence and inductively-coupled plasma atomic emission analysis upon acid digestion using paint currently sold in Côte d'Ivoire and samples of older US paint. Comparison of the three different methods indicates a detection limit for the Lumetallix kit of approximately 500 mg kg-1 (ppm) Pb in paint, with a sensitivity of 95 % and selectivity of 94 % relative to that threshold (n = 76). This detection limit is an order of magnitude below the US definition of Pb-based paint of 0.5 % (5,000 ppm) Pb by weight. SIGNIFICANCE: Because the kit is easy to use, exposed paint posing a risk could reliably be screened at scale by the general public. Any follow-up for confirmation and mitigation based on XRF measurements will need to consider that Pb-based paint covered with low-Pb paint will not respond to the kit but will be detected by XRF through the overpainted layer.

Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles.

We have carried out a computational structure-based design of new potent pyrrolidine carboxamide (PCAMs) inhibitors of enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis (MTb). Three-dimensional (3D) models of InhA-PCAMx complexes were prepared by in situ modification of the crystal structure of InhA-PCAM1 (Protein Data Bank (PDB) entry code: 4U0J), the reference compound of a training set of 20 PCAMs with known experimental inhibitory potencies (IC50(exp)). First, we built a gas phase quantitative structure-activity relationships (QSAR) model, linearly correlating the computed enthalpy of the InhA-PCAM complex formation and the IC50(exp). Further, taking into account the solvent effect and loss of inhibitor entropy upon enzyme binding led to a QSAR model with a superior linear correlation between computed Gibbs free energies (ΔΔGcom) of InhA-PCAM complex formation and IC50(exp) (pIC50(exp) = -0.1552·ΔΔGcom + 5.0448, R² = 0.94), which was further validated with a 3D-QSAR pharmacophore model generation (PH4). Structural information from the models guided us in designing of a virtual combinatorial library (VL) of more than 17 million PCAMs. The VL was adsorption, distribution, metabolism and excretion (ADME) focused and reduced down to 1.6 million drug like orally bioavailable analogues and PH4 in silico screened to identify new potent PCAMs with predicted IC50(pre) reaching up to 5 nM. Combining molecular modeling and PH4 in silico screening of the VL resulted in the proposed novel potent antituberculotic agent candidates with favorable pharmacokinetic profiles.

Can quantum-mechanical calculations yield reasonable estimates of hydrogen-bonding acceptor strength? The case of hydrogen-bonded complexes of methanol.

The thermodynamics and some vibrational properties of hydrogen-bonded complexes of methanol with 23 hydrogen-bond acceptors (HBAs) have been determined in CCl(4) by FTIR spectrometry. The experimental sample contains carbon, nitrogen, oxygen, sulfur, fluorine, and chlorine organic bases and covers an energetic range of 13 kJ mol(-1) in the basicity scale (-ΔG), 22 kJ mol(-1) in the affinity scale (-ΔH), and 400 cm(-1) in the spectroscopic scale (Δν((OH))) (from benzene to trimethylphosphane oxide and amines). The experimental results in CCl(4) are compared to those computed in the gas phase at various levels of theory. Ninety five percent of the variance of the red shift and 89% of the variance of the intensification of the OH stretching upon hydrogen bonding are explained by gas-phase B3LYP/6-31+G(d,p) calculations. However, this level does not satisfactorily explain the thermodynamic properties. Only 68% of the variance of the methanol affinity (-ΔH) is taken into account. MP2/aug-cc-pVTZ//B3LYP/6-31+G(d,p) affinity calculations raise the explanation to 77% for all HBAs and to 93% when three outliers (Me(2)SO, Me(3)PO, and tetrahydrothiophene) are excluded. Discrepancies are analyzed in terms of experimental errors, calculation approximations, and solvation.

B3LYP and MP2 calculations of the enthalpies of hydrogen-bonded complexes of methanol with neutral bases and anions: comparison with experimental data.

To perfect a method for building a theoretical hydrogen-bond basicity scale, the enthalpy of hydrogen bonding between methanol and thirteen neutral and anionic bases (MeOH, MeNH2, Me2NH, Et2NH, Me3N, Et3N, Br-, CN-, SH-, Cl-, HCOO-, MeO-, F-) was calculated by DFT and ab initio methods. The theoretical results were compared to selected experimental ones. It appears that B3LYP/6-31+G(d,p) calculations are satisfactory for optimizing the geometry of complexes and giving a general order of basicity. However, they are deficient for reproducing the large effect of alkyl groups on the hydrogen-bond basicity of amines. This deficiency is explained by intermolecular perturbation theory calculations, which show that the alkylation of nitrogen dramatically increases the dispersion energy component not taken into account by the B3LYP functional. Of the methods considered, only MP2/aug-cc-pVTZ calculations are capable of reproducing the binding enthalpy within the experimental error for the first-row acceptor atoms N, O, and F, and of accounting for dispersion effects created by alkylation at the hydrogen-bond acceptor site.